Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
Int J Mol Sci ; 25(3)2024 Feb 02.
Artigo em Inglês | MEDLINE | ID: mdl-38339106

RESUMO

Gestational diabetes mellitus (GDM) is considered one of the most common diseases that occur during pregnancy. In addition to increasing the risk of numerous complications throughout gestation, it is also believed to have a long-term potential to impact the risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular disease for the mother and her offspring. While there are clear guidelines for healthy weight gain in pregnancy depending on pre-pregnancy BMI, as well as dietary and training recommendations to achieve this, an increasing number of women are experiencing excessive gestational weight gain (EGWG). Such patients have a higher risk of developing GDM and gestational hypertension, as well as requiring caesarian delivery. Dipeptidyl peptidase-4 (DPP-4) is a glycoprotein that seems to play an important role in glucose metabolism, and inhibition of its activity positively affects glucose regulation. The aim of our study was to compare DPP-4 concentrations in patients with GDM and EGWG with healthy women. DPP-4 levels were assessed in serum and urine samples collected on the day of delivery. The bioelectrical impedance analysis (BIA) method was also used to analyze the body composition of patients on the second day of the postpartum period. DPP-4 serum concentrations were significantly higher in patients in the GDM and EGWG groups compared to healthy women. Urinary DPP-4 concentrations were significantly higher in the control and GDM groups than in the EGWG group. Serum DPP-4 levels were positively correlated with BMI measured before pregnancy, on the delivery day, and in the early postpartum period, among other factors. According to our knowledge, this is the first study to determine DPP-4 levels in EGWG patients. DPP-4 may be related to the occurrence of GDM and EGWG; however, this requires further research.


Assuntos
Diabetes Mellitus Tipo 2 , Diabetes Gestacional , Dipeptidil Peptidase 4 , Ganho de Peso na Gestação , Feminino , Humanos , Gravidez , Índice de Massa Corporal , Diabetes Gestacional/sangue , Diabetes Gestacional/diagnóstico , Ganho de Peso na Gestação/fisiologia , Aumento de Peso , Dipeptidil Peptidase 4/sangue , Dipeptidil Peptidase 4/química , Dipeptidil Peptidase 4/urina
2.
Kidney Blood Press Res ; 46(4): 502-513, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34237745

RESUMO

BACKGROUND: The age-related increase in blood pressure in spontaneously hypertensive rats (SHRs) is associated to cardiac hypertrophy, heart failure, and renal injury. Here, we investigated for the first time the urinary enzymatic activities of glutamil aminopeptidase (GluAp), alanyl aminopeptidase (AlaAp), dipeptidyl peptidase-4 (DPP4), and Klotho urinary levels, proteins that are strongly expressed in the kidney, as early biomarkers of renal injury in SHRs. METHODS: Male SHR and Wistar Kyoto (WKY) rats were studied from 2 to 8 months old. Systolic blood pressure (SBP), the heart rate (HR), metabolic variables, and urinary markers were measured monthly. At the end of the study, a histopathological evaluation of the kidney was performed. RESULTS: Kidneys of SHR did not develop signs of relevant histopathological changes, but showed increased glomerular area and cellularity. Plasma creatinine was decreased, and creatinine clearance was augmented in SHR at the end of the study. Urinary excretion of Klotho was higher in SHR at 5 and 8 months old, whereas plasma Klotho levels were similar to WKY. GluAp, AlaAp, and DPP4 urinary activities were increased in SHR throughout the time-course study. A positive correlation between glomerular area and cellularity with creatinine clearance was observed. Urinary GluAp, AlaAp, DPP4, and Klotho showed positive correlations with SBP. CONCLUSIONS: GluAp, AlaAp, DPP4, and Klotho in the urine are useful tools for the evaluation of renal damage at early stages, before the whole histopathological and biochemical manifestations of renal disease are established. Moreover, these observations may represent a novel and noninvasive diagnostic approach to assess the evolution of kidney function in hypertension and other chronic diseases.


Assuntos
Hipertensão/urina , Nefropatias/urina , Animais , Biomarcadores/urina , Antígenos CD13/urina , Dipeptidil Peptidase 4/urina , Glutamil Aminopeptidase/urina , Hipertensão/complicações , Nefropatias/etiologia , Proteínas Klotho/análise , Masculino , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY
3.
Am J Physiol Renal Physiol ; 320(3): F285-F296, 2021 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-33346727

RESUMO

This study investigated the molecular mechanisms underlying the antiproteinuric effect of DPP4 inhibition in 5/6 renal ablation rats and tested the hypothesis that the urinary activity of DPP4 correlates with chronic kidney disease (CKD) progression. Experiments were conducted in male Wistar rats who underwent 5/6 nephrectomy (Nx) or sham operation followed by 8 wk of treatment with the DPP4 inhibitor (DPP4i) sitagliptin or vehicle. Proteinuria increased progressively in Nx rats throughout the observation period. This increase was remarkably mitigated by sitagliptin. Higher levels of proteinuria in Nx rats compared to control rats were accompanied by higher urinary excretion of retinol-binding protein 4, a marker of tubular proteinuria, as well as higher urinary levels of podocin, a marker of glomerular proteinuria. Retinol-binding protein 4 and podocin were not detected in the urine of Nx + DPP4i rats. Tubular and glomerular proteinuria was associated with the reduced expression of megalin and podocin in the renal cortex of Nx rats. Sitagliptin treatment partially prevented this decrease. Besides, the angiotensin II renal content was significantly reduced in the Nx rats that received sitagliptin compared to vehicle-treated Nx rats. Interestingly, both urinary DPP4 activity and abundance increased progressively in Nx rats. Additionally, urinary DPP4 activity correlated positively with serum creatinine levels, proteinuria, and blood pressure. Collectively, these results suggest that DPP4 inhibition ameliorated both tubular and glomerular proteinuria and prevented the reduction of megalin and podocin expression in CKD rats. Furthermore, these findings suggest that urinary DPP4 activity may serve as a biomarker of renal disease and progression.


Assuntos
Dipeptidil Peptidase 4/urina , Inibidores da Dipeptidil Peptidase IV/farmacologia , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Rim/efeitos dos fármacos , Proteína-2 Relacionada a Receptor de Lipoproteína de Baixa Densidade/metabolismo , Proteínas de Membrana/metabolismo , Proteinúria/prevenção & controle , Insuficiência Renal Crônica/prevenção & controle , Fosfato de Sitagliptina/farmacologia , Angiotensina II/metabolismo , Animais , Biomarcadores/urina , Modelos Animais de Doenças , Fibrose , Rim/enzimologia , Rim/patologia , Masculino , Proteinúria/enzimologia , Proteinúria/patologia , Proteinúria/urina , Ratos Wistar , Insuficiência Renal Crônica/enzimologia , Insuficiência Renal Crônica/patologia , Insuficiência Renal Crônica/urina , Proteínas Plasmáticas de Ligação ao Retinol/urina , Transdução de Sinais
4.
Proteomics Clin Appl ; 13(2): e1800144, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30632692

RESUMO

PURPOSE: Chronic kidney disease (CKD) is a serious complication of hyperglycemia and treatment options to slow its progression are scarce. Dipeptidyl peptidase-4 (DPP-4) inhibitors are common glucose-lowering drugs in type 2 diabetes (T2D). Among these, linagliptin has been suggested to exert kidney protective effects. It is investigated whether an effect of linagliptin on kidney function could be unmasked by characterizing the urinary proteome profile (UPP) in albuminuric T2D individuals. EXPERIMENTAL DESIGN: Participants of the MARLINA-T2D trial (NCT01792518) are randomized 1:1 to receive either linagliptin 5 mg or placebo for 24 weeks. A previously developed proteome-based classifier, CKD273, is assessed. RESULTS: Results confirm a significant correlation between CKD273 and clinical kidney parameters as well as with eGFR decline. Patient stratification using CKD273 at baseline, show a trend toward attenuation of renal function loss in high CKD-risk patients treated with linagliptin. Moreover, characterized are linagliptin affected peptides of which the majority contained a DPP-4 target sequence. CONCLUSIONS AND CLINICAL RELEVANCE: CKD273 is a promising tool for identifying patients at high risk for CKD progression and may unmask a potential of linagliptin to slow progressive kidney function loss in high CKD-risk patients. UPP characterization reveals a significant impact of linagliptin on urinary peptides.


Assuntos
Dipeptidil Peptidase 4/urina , Inibidores da Dipeptidil Peptidase IV/farmacologia , Rim/efeitos dos fármacos , Linagliptina/farmacologia , Proteômica , Feminino , Humanos , Masculino
5.
Medicine (Baltimore) ; 97(26): e11287, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29953010

RESUMO

The current methods of monitoring the activity of lupus nephritis (LN) may cause unnecessary hospital visits or delayed immunosuppressive therapy. We aimed to find a urinary biomarker that could be developed as a home-based test for monitoring the activity of LN.Urine samples were collected immediately before a renal biopsy from patients of suspected active LN, and also from patients with inactive LN, systemic lupus erythematous without LN or healthy controls. Biomarker search was conducted on a cytokine antibody array and confirmation was done by quantitative evaluation with enzyme-linked immunosorbent assay. The Mann-Whiney test or Student t test was used to compare the levels of 9 cytokines between different groups. The sensitivity and specificity of each cytokine for diagnosis of LN was evaluated by receiver operating characteristic curve. A rapid test based on colloidal gold immunochromatography was then developed for bedside or home use. Furthermore, an experimental e-healthcare system was constructed for recording and sharing the results of the rapid test a cloud-assisted internet of things (IoT) consisting of a sensing device, an IoT device and a cloud server.Adiponectin (Acrp30), soluble intercellular cell adhesion molecule-1 (sICAM-1), neural cell adhesion molecule 1 (NCAM-1), and CD26 were significantly higher in urine samples of active LN patients. sICAM-1 appeared more sensitive and specific among these candidates. When the cut-off value of sICAM-1 was set at 1.44 ng/mL, the sensitivity reached 98.33% with a specificity at 85.71%. The sICAM-1 strip test showed comparable sensitivity of 95% and a specificity of 83.3% for assessing the LN activity. Meanwhile, the e-healthcare system was able to conveniently digitize and share the sICAM-1 rapid test results.sICAM-1 appeared to be an excellent biomarker for monitoring LN activity. The e-healthcare system with cloud-assisted IoT could assist the digitalization and sharing of the bedside or home-based sICAM-1 test results.


Assuntos
Molécula 1 de Adesão Intercelular/urina , Nefrite Lúpica/imunologia , Nefrite Lúpica/urina , Adiponectina/imunologia , Adiponectina/urina , Adulto , Idoso , Biomarcadores , Antígeno CD56/imunologia , Antígeno CD56/urina , Dipeptidil Peptidase 4/imunologia , Dipeptidil Peptidase 4/urina , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Molécula 1 de Adesão Intercelular/imunologia , Lúpus Eritematoso Sistêmico/imunologia , Lúpus Eritematoso Sistêmico/urina , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença
6.
Aviat Space Environ Med ; 84(8): 859-63, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23926664

RESUMO

BACKGROUND: The recent evolution of genomics and subsequently proteomics offers a major advance in the ability to understand individual human variation in disease and the molecular level changes induced by certain environmental exposures. This original study examines urinary proteome composition to enable the understanding of molecular homeostatic mechanisms in spaceflight and presents the potential for early detection of subclinical disease, microgravity risk mitigation strategies, and countermeasure development for exploration-class missions. METHODS: The urinary proteome composition of six Russian cosmonauts (men, ages 35-51) who flew long-duration missions of 169-199 d was determined 30 d before flight and compared to repeat studies 1 and 7 d postflight. RESULTS: There were 430 proteins identified. Of those, 15 proteins originated in the renal tissues. Of the 15 urinary proteins, 10 were consistently present in the urine. However, the presence of five of the urinary proteins--neutral endopeptidase (NEP), afamin (AFAM), aquaporin-2 (AQP2), aminopeptidase A (AMPE), and dipeptidyl peptidase 4 (DPP4)--was dependent on spaceflight exposure. DISCUSSION: Proteomic investigation of pre- and postflight urine and bioinformation approaches to proteome analysis provide important data relative the mechanism of kidney function in spaceflight. In this initial study, we determined that the evaluation of urinary proteins may help investigators understand changes that are occurring in microgravity. Once additional ground-based and in-flight data are collected, it is feasible to develop targeted studies for tracking specific spaceflight related changes, determine countermeasure and risk-mitigation effectiveness, and possibly detect subclinical disease in flight crewmembers.


Assuntos
Voo Espacial , Adulto , Aquaporina 2/urina , Proteínas Sanguíneas/urina , Proteínas de Transporte/urina , Cromatografia Líquida , Dipeptidil Peptidase 4/urina , Fator de Crescimento Epidérmico/urina , Glutamil Aminopeptidase/urina , Glicoproteínas/urina , Humanos , Cininogênios/urina , Proteína-2 Relacionada a Receptor de Lipoproteína de Baixa Densidade/análise , Masculino , Espectrometria de Massas , Pessoa de Meia-Idade , Neprilisina/urina , Osteopontina/urina , Receptores de Superfície Celular/análise , Albumina Sérica , Albumina Sérica Humana , Calicreínas Teciduais/urina , Uromodulina/urina , Molécula 1 de Adesão de Célula Vascular/urina , beta-Defensinas/urina
7.
PLoS One ; 7(7): e37279, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22808001

RESUMO

Urinary exosomes represent a precious source of potential biomarkers for disease biology. Currently, the methods for vesicle isolation are severely restricted by the tendency of vesicle entrapment, e.g. by the abundant Tamm-Horsfall protein (THP) polymers. Treatment by reducing agents such as dithiothreitol (DTT) releases entrapped vesicles, thus increasing the final yield. However, this harsh treatment can cause remodelling of all those proteins which feature extra-vesicular domains stabilized by internal disulfide bridges and have detrimental effects on their biological activity. In order to optimize exosomal yield, we explore two vesicle treatment protocols - dithiothreitol (DTT) and 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic (CHAPS) - applied to the differential centrifugation protocol for exosomal vesicle isolation. The results show that CHAPS treatment does not affect vesicle morphology or exosomal marker distribution, thus eliminating most of THP interference. Moreover, the recovery and preservation of catalytic activity of two trans-membrane proteases, dipeptidyl peptidase IV and nephrilysin, was examined and found to be clearly superior after CHAPS treatment compared to DTT. Finally, proteomic profiling by mass spectrometry (MS) revealed that 76.2% of proteins recovered by CHAPS are common to those seen for DTT treatment, which illustrates underlining similarities between the two approaches. In conclusion, we provide a major improvement to currently-utilized urinary vesicle isolation strategies to allow recovery of urinary vesicles without the deleterious interference of abundant urinary proteins, while preserving typical protein folding and, consequently, the precious biological activity of urinary proteins which serve as valuable biomarkers.


Assuntos
Bioensaio , Ácidos Cólicos/química , Detergentes/química , Exossomos/química , Exossomos/ultraestrutura , Adsorção , Adulto , Biomarcadores/química , Biomarcadores/urina , Centrifugação , Dipeptidil Peptidase 4/química , Dipeptidil Peptidase 4/urina , Ditiotreitol/química , Feminino , Humanos , Masculino , Espectrometria de Massas , Proteínas de Membrana/química , Proteínas de Membrana/urina , Microscopia Eletrônica de Transmissão , Proteômica , Uromodulina
8.
Diab Vasc Dis Res ; 9(4): 301-8, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22388283

RESUMO

The present study was designed to identify the changes in microvesicle-dipeptidyl peptidase-IV (DPP IV) levels in human urine and serum, and to determine whether there were correlations with the severity of diabetic kidney disease (DKD). A total of 127 patients with type 2 diabetes mellitus (T2DM) were divided into three groups according to the urinary albumin/ creatinine ratio (UACR): microalbuminuria group (n = 50); macroalbuminuria group (n = 34) and normoalbuminuria group (n = 43), and 34 age- and sex-matched non-diabetic healthy subjects were selected as controls. Microvesicle-bound DPP IV and free urinary DPP IV were separated by a filtra-centrifugation method. The total microvesicles were captured by a specific monoclonal antibody, AD-1. DPP IV activity was determined by measuring the cleavage of chromogenic free 4-nitroaniline from Gly-Pro-p-nitroanilide at 405 nm with an ELISA plate reader. DPP IV protein levels were determined by ELISA and Western blot. Our results showed that the microvesicle-bound type was the major form of DPP IV in urine; the urinary microvesicle-DPP IV excretion of each T2DM group was significantly higher compared with controls. The urinary microvesicle-DPP IV level was positively correlated with UACR in patients with T2DM. These findings suggest that the urinary level of microvesicle-bound DPP IV is associated with the severity of DKD.


Assuntos
Diabetes Mellitus Tipo 2/complicações , Nefropatias Diabéticas/enzimologia , Dipeptidil Peptidase 4/urina , Idoso , Albuminúria/diagnóstico , Albuminúria/enzimologia , Albuminúria/etiologia , Albuminúria/urina , Biomarcadores/sangue , Biomarcadores/urina , Western Blotting , Estudos de Casos e Controles , Centrifugação , Creatinina/urina , Nefropatias Diabéticas/sangue , Nefropatias Diabéticas/diagnóstico , Nefropatias Diabéticas/etiologia , Nefropatias Diabéticas/urina , Dipeptidil Peptidase 4/sangue , Ensaio de Imunoadsorção Enzimática , Exossomos/enzimologia , Exossomos/ultraestrutura , Feminino , Humanos , Testes de Função Renal , Modelos Lineares , Masculino , Microscopia Eletrônica , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Índice de Gravidade de Doença , Urinálise , Urina/química , Urina/citologia
9.
Ann Hepatol ; 6(4): 242-50, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18007554

RESUMO

OBJECTIVE(S): Non-alcoholic steatohepatitis (NASH) is a chronic liver disease with unknown etiology. The insulin resistance, immune mechanisms and oxidative stress are the main factors in its pathogenesis. Dipeptidyl peptidase IV (DPPIV) or CD26 is a protein with endocrine and immune functions. This study aimed to elicudate the changes related to DPPIV in NASH patients. METHODS: Serum and urinary DPPIV activities were measured in 31 NASH patients and 17 healthy controls. The liver biopsies of 29 patients were immunolabeled for CD26. RESULTS: The mean age of patients were 46 +/- 11 years and 14 (45%) of them were female. The serum DPPIV activity was higher in patients (57.3 +/- 7.8 U/L) than controls (43.6 +/- 10.6 U/L) (p < 0.0001), and correlated with the histopathological grade (p = 0.038, r = 0.373) and hepatosteatosis (p = 0.018, r = 0.423) but not with stage (p = 0.286), class (p = 0.286) or CD26 staining (p = 0.743). The urinary DPPIV activity was similar in patients (1.52 +/- 0.94 U/mmol creatinine) and controls (1.37 +/- 0.68 U/mmol creatinine) (p = 0.861). Three acinar zones of liver had equal CD26 expression (p = 0.076). The intensity of CD26 immunostaining was correlated with histopathological grade (p = 0.001) and hepatosteatosis (p = 0.003) but no correlation with stage or class could be detected (p = 0.610 and 0.956, respectively). In CONCLUSIONS: The serum DPPIV activity and the staining intensity of CD26 in liver are correlated with histopathologic grade of NASH and hepatosteatosis. DPPIV can be proposed as a novel candidate with several potential functions in NASH pathogenesis.


Assuntos
Dipeptidil Peptidase 4/sangue , Dipeptidil Peptidase 4/urina , Fígado Gorduroso/enzimologia , Hepatite/enzimologia , Adulto , Fígado Gorduroso/patologia , Feminino , Humanos , Fígado/enzimologia , Fígado/patologia , Masculino , Pessoa de Meia-Idade
10.
J Lab Clin Med ; 134(1): 56-67, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10402060

RESUMO

Dipeptidyl peptidase IV (CD26) is a membrane-associated enzyme that is expressed on the surface of T cells and on the hepatocyte brush border. In a soluble form it is present in serum. CD26 has been implicated in the regulation of T cell activation and in the metabolism of hormones and cytokines. Dipeptidyl peptidase (DPP) activity is elevated in the urine and serum of patients with biliary atresia (BA). To clarify the role of cholestasis in the development of increased serum and urinary DPP/CD26 activity, we studied the mechanism of activity increase in experimentally induced cholestasis of CD26-deficient and wild-type rats. The clinical utility of serum and urinary DPP/CD26 activity measurements was tested in adult and pediatric patients with hepatobiliary diseases and in liver transplant recipients. The results establish CD26-associated serum DPP activity as a novel, clinically useful marker of cholestasis and demonstrate that in contrast with alkaline phosphatase levels, DPP levels do not change in metastatic bone disease. Additionally, DPP activity is useful as a urinary test of cholestasis in infants who are not receiving nephrotoxic medication.


Assuntos
Biomarcadores/sangue , Biomarcadores/urina , Colestase/enzimologia , Dipeptidil Peptidase 4/metabolismo , Fosfatase Alcalina/sangue , Animais , Bilirrubina/sangue , Neoplasias Ósseas/sangue , Neoplasias Ósseas/enzimologia , Neoplasias Ósseas/secundário , Estudos de Casos e Controles , Colestase/sangue , Colestase/urina , Dipeptidil Peptidase 4/sangue , Dipeptidil Peptidase 4/urina , Feminino , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Hepatopatias/sangue , Hepatopatias/enzimologia , Hepatopatias/urina , Ratos , Ratos Endogâmicos BUF , Ratos Endogâmicos F344
11.
Eur J Pediatr Surg ; 8(4): 244-6, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9783150

RESUMO

The urinary enzymes Gamma Glutamyl Transferase (GGT), Alkaline Phosphatase (ALP), Leucine-Arylamidase (LAS), and Dipeptidyl-Peptidase-IV (DPP-IV) were measured before and after endoscopic treatment of vesico-ureteric reflux (VUR) in two groups of twenty children. Ten patients had undergone successful endoscopic corrective surgery for VUR, another 10 patients had unsuccessful endoscopic intervention. After successful treatment the activity of LAS in the urine did not change, but GGT, ALP and DPP-IV activity in the urine was 2-5 times higher than before treatment (P < 0.03 for all three enzymes). Considerable changes of urinary enzyme activity were not observed following unsuccessful endoscopic treatment. Our data and the literature are contradictory. However, this contradiction might be explained by the differences in urine sampling methods. Our patients received the same chemoprophylactic drug at the time of both urine samplings, a point not considered by other researchers. The extent of increase of enzyme activity after endoscopic treatment of VUR did not reach the level that would permit the use of investigated enzymes for screening, because the observed changes did not exceed the limits of the normal range.


Assuntos
Escleroterapia/métodos , Refluxo Vesicoureteral/enzimologia , Refluxo Vesicoureteral/terapia , Fosfatase Alcalina/urina , Estudos de Casos e Controles , Criança , Dipeptidil Peptidase 4/urina , Feminino , Humanos , Leucil Aminopeptidase/urina , Masculino , Soluções Esclerosantes/uso terapêutico , gama-Glutamiltransferase/urina
12.
Eur J Clin Chem Clin Biochem ; 35(4): 281-6, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9166970

RESUMO

The enzyme excretion of dipeptidylpeptidase IV (EC 3.4.14.5), gamma-glutamyltransferase (EC 2.3.2.2), and alanine aminopeptidase (EC 3.4.11) was pursued in three different age groups of female volunteers over a period of 70 days. The first group (1-3 years: n = 6) consisted of girls living in a children's home, the second (26-50 years, n = 7) of medical staff and the third (65-87 years, n = 7) of the inhabitants of an old-age home. Subsequent to basic statistics the excretion patterns were analyzed by spectral analysis with the maximum entropy method. The mean values of all enzymes displayed a distinct age-dependency. The highest levels of enzyme excretion were found in the early childhood. In all groups infradian changes of enzyme excretion were detected. In excretion of gamma-glutamyltransferase, longer periods between 12 and 24 days predominated during the early childhood, whereas in the middle, and in particular in the higher age, shorter dominant periods occurred more frequently. The excretion of alanine aminopeptidase displayed a similar tendency. Circaseptan periods (7 +/- 1 days) were rarely observed among the dominant periods of the maximum entropy method spectra. A correlation analysis of the individual excretion patterns revealed that the excretion of all three bush-border enzymes is most tightly correlated in the early childhood (coefficients of correlation up to 0.9). In contrast, the correlation between enzymes and creatinine excretion was low in all age groups.


Assuntos
Envelhecimento/urina , Antígenos CD13/urina , Dipeptidil Peptidase 4/urina , Periodicidade , gama-Glutamiltransferase/urina , Adulto , Idoso , Idoso de 80 Anos ou mais , Pré-Escolar , Feminino , Humanos , Lactente , Pessoa de Meia-Idade
13.
Srp Arh Celok Lek ; 124 Suppl 1: 43-4, 1996.
Artigo em Sérvio | MEDLINE | ID: mdl-9102926

RESUMO

Urinary levels of beta 2 microglobulin (beta 2 MG) and dipeptidipeptidse IV (DPP IV) were measured in 30 insulin dependent diabetes mellitus children aged 5 to 18 years. The control group consisted of 30 healthy children. Metabolic control (HbA1C) and the duration of diabetes were directly correlated with the levels of beta 2 MG and DPP IV. Beta 2 MG urinary levels were significantly increased in the diabetic group (MV = 0.340 +/- 0.076 mg/l) as compared with the controls (MV = 0.081 +/- 0.012 mg/l, p < 0.05). These values correlated only with the duration of diabetes and not with the HbA1C. DPP IV excretion was elevated in all diabetic patients (MV = 6.40 +/- 0.83 j/l). Significant correlations were not identified between urinary DPPIV excretion and the duration of diabetes and metabolic control.


Assuntos
Diabetes Mellitus Tipo 1 , Nefropatias Diabéticas/diagnóstico , Túbulos Renais/fisiopatologia , Adolescente , Criança , Pré-Escolar , Diabetes Mellitus Tipo 1/fisiopatologia , Nefropatias Diabéticas/fisiopatologia , Dipeptidil Peptidase 4/urina , Humanos , Microglobulina beta-2/urina
14.
Pediatr Nephrol ; 9(4): 419-22, 1995 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7577399

RESUMO

The potential tubulotoxicity of tobramycin and cefotaxim were assessed in neonates by measuring the urinary level of adenosine deaminase binding protein (ABP) and urinary alpha 1-microglobulin and beta 2-microglobulin. In a prospective study, 33 neonates who received tobramycin and cefotaxim for suspected neonatal sepsis were compared with 48 untreated newborns during the first 10 days of life. The urinary concentrations of ABP and its excretion rates, corrected for body weight and body surface area, were significantly increased from the 1st day of treatment. Urinary alpha 1-microglobulin and beta 2-microglobulin were not elevated under tobramycin and cefotaxim during the first 2 days of treatment. We conclude that ABP may be a sensitive marker for the detection of proximal renal tubular injury during tobramycin and cefotaxim treatments of neonates. The increase in urinary ABP which occurs before an elevation of urinary alpha 1-microglobulin and beta 2-microglobulin may reflect earlier structural than functional alterations. However, since none of the treated infants had signs of electrolyte disorders or glomerular dysfunction, the clinical relevance of ABP measurement should be reevaluated.


Assuntos
Antibacterianos/efeitos adversos , Dipeptidil Peptidase 4/urina , Tobramicina/efeitos adversos , Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Biomarcadores/urina , Cefotaxima/efeitos adversos , Cefotaxima/urina , Cefalosporinas/urina , Creatinina/urina , Humanos , Recém-Nascido , Estudos Prospectivos , Tobramicina/uso terapêutico , Microglobulina beta-2/urina
15.
Ren Fail ; 17(4): 365-75, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7569109

RESUMO

Angiotensin I converting enzyme (ACE) activity was measured in serum, urine, and tissues of rats with acute renal failure (ARF) induced by glycerol. Glycerol-injected rats were subdivided in three groups according to the urinary volume: oliguric, nonoliguric, and polyuric. The damage to the proximal tubule was evident by (a) the histological analysis at light and electron microscopy level, (b) the augmented urinary excretion of the enzymes dipeptidyl aminopeptidase IV and N-acetyl-beta-D-glucosaminidase, and (c) the low molecular weight proteinuria pattern. On the other hand, the appearance of the glomeruli at the ultrastructural level was normal. These data suggest that the increased urinary excretion of enzymes and proteins in these rats is a consequence of the tubular injury. ARF was markedly higher in the oliguric rats. Urine ACE activity increased in the rats of the three groups, but statistical significance was reached only in the oliguric rats. Serum ACE activity increased in the oliguric rats and tissue ACE activity did not change. It is concluded that the high urinary ACE in glycerol-treated rats is associated with the damage to the kidney tubules. These data support the contention that urinary ACE may be another marker of injury to the proximal tubule.


Assuntos
Injúria Renal Aguda/enzimologia , Peptidil Dipeptidase A/metabolismo , Acetilglucosaminidase/urina , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/patologia , Animais , Dipeptidil Peptidase 4/urina , Glicerol , Córtex Renal/patologia , Glomérulos Renais/patologia , Túbulos Renais Proximais/patologia , Masculino , Microscopia Eletrônica , Peptidil Dipeptidase A/urina , Ratos , Ratos Wistar
16.
Ren Fail ; 17(4): 377-88, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7569110

RESUMO

Angiotensin I converting enzyme (ACE) was measured in urine, serum, and tissues from rats with acute renal failure (ARF) induced by a single subcutaneous injection (15 mg/kg BW) of uranyl nitrate (UN). Urine was collected daily until day 5, when rats were sacrificed by decapitation for the obtention of blood serum and tissues. Other groups of rats were sacrificed on days 1 and 2. These rats showed proteinuria and polyuria. The damage to the kidney proximal tubule was shown by (a) histological analysis at light and electron microscopy levels on days 1, 2, and 5, (b) the increase in urinary excretion of dipeptidyl aminopeptidase IV and N-acetyl-beta-D-glucosaminidase on days 1-5, and (c) the low molecular weight proteinuria pattern on day 1. In addition, the histological analysis at the ultrastructural level showed normal glomeruli appearance on days 1 and 2, but structural alterations on day 5. These data suggest that the increased urinary excretion of enzymes and proteins is a consequence of the tubular injury on days 1 and 2, and of tubular and glomerular injury on day 5. ACE activity increased in urine on days 1-5 and in serum on day 5. Tissue ACE activity increased in lung, small intestine, and adrenal glands; and remained unchanged in testis, aorta, brain, kidney, heart, and liver. Our data suggest that: (a) the increase in serum ACE may be secondary to the changes in tissue ACE activity, and (b) the urine ACE increase may be due to the kidney proximal tubule damage. This work supports the contention that an increase in urine ACE may be an indicator of injury to the proximal tubule.


Assuntos
Injúria Renal Aguda/enzimologia , Peptidil Dipeptidase A/metabolismo , Acetilglucosaminidase/urina , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/patologia , Animais , Dipeptidil Peptidase 4/urina , Córtex Renal/patologia , Glomérulos Renais/patologia , Túbulos Renais Proximais/patologia , Masculino , Microscopia Eletrônica , Peptidil Dipeptidase A/urina , Ratos , Ratos Wistar , Fatores de Tempo , Nitrato de Uranil
18.
J Clin Lab Anal ; 9(2): 113-8, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7714663

RESUMO

We synthesized a new substrate glycyl-L-proline 3,5-dibromo-4-hydroxyanilide (Gly-Pro-DBAP), for dipeptidyl peptidase IV (DPPIV). Its hydrolysis by DPPIV resulted in the formation of a chromophore, 2,6-dibromophenol-indo-p-xylenol, and its maximal absorption wavelength (600 nm) was longer than that of p-nitroaniline (415 nm) released from conventional substrate, glycyl-L-proline p-nitroanilide (Gly-Pro-pNA). We also established the rate assay for urinary DPPIV activity using Gly-Pro-DBAP. The optimum pH was between 8.5 and 9.0. The apparent Km was 1.1 mmol/1. The detectable range was 2.5-350 U/l. No changes in blank values occurred throughout the enzyme reaction in the optimum pH. Its value was also much lower than Gly-Pro-pNA. CVs for within-run and between-run were 1.1% (n = 10) and 3.0% (n = 10), respectively. Among tested peptidases, only DPPIV could hydrolyze Gly-Pro-DBAP. Among the protease inhibitors, only two, diprotin-A and phenylmethylsulfonyl fluoride (PMSA), could inhibit DPPIV activity. The present method did not interfere with urinary ingredients such as hemoglobin. The correlation between the present (y) and conventional (x) methods is presented by the equation y = 1.121x + 0.096 (r = 0.993). Thus the present method provides practical advantages over the conventional method for routine laboratory use.


Assuntos
Anilidas/química , Colorimetria/métodos , Dipeptídeos/química , Dipeptidil Peptidase 4/urina , Oxirredutases atuantes sobre Doadores de Grupo CH-CH , Creatinina/urina , Dipeptidil Peptidases e Tripeptidil Peptidases/antagonistas & inibidores , Ativação Enzimática , Humanos , Concentração de Íons de Hidrogênio , Cinética , Oligopeptídeos , Oxirredutases/urina , Inibidores de Proteases , Especificidade por Substrato , Compostos de Tosil
19.
Clin Chim Acta ; 228(2): 123-32, 1994 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7988029

RESUMO

Markers of renal tubular injury were examined in 21 patients (16 male, 5 female, mean age 57.4 years) undergoing cardiac surgery utilising cardiopulmonary bypass. Postoperative urine outputs were very high (200-250 ml/h at 1-2 h), decreasing to 100 ml/h by 6 h. Although creatinine clearances did not vary significantly in the postoperative period (P = 0.16), significant changes were noted in the urinary concentrations of three tubular markers relative to creatinine concentration (P < 0.001). Urinary beta 2-microglobulin increased from negligible levels (median 0.01 mg/mmol creatinine) to peak at 4 h (median 4.55 mg/mmol), in part due to interference with its reabsorption by the plasma volume expander Haemaccel. Concentrations of the brush border antigen adenosine deaminase binding protein increased 6-fold, from a median of 5.03 arbitrary units (AU)/mumol to 31.2 AU/mumol at 48 h. The lysosomal enzyme N-acetyl-beta-D-glucosaminidase increased nearly 4-fold, from 0.68 units/mmol to 2.64 units/mmol at 48 h. Our results suggest that cardiac surgery utilising cardiopulmonary bypass is associated with acute tubular injury which can occur in the absence of overt changes in creatinine clearance.


Assuntos
Ponte Cardiopulmonar/efeitos adversos , Nefropatias/etiologia , Túbulos Renais Proximais , Acetilglucosaminidase/urina , Creatinina/urina , Dipeptidil Peptidase 4/urina , Feminino , Humanos , Nefropatias/fisiopatologia , Túbulos Renais Proximais/fisiopatologia , Lisossomos/enzimologia , Masculino , Pessoa de Meia-Idade , Valores de Referência , Urina , Microglobulina beta-2/urina
20.
Enzyme Protein ; 48(3): 174-82, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-8589804

RESUMO

In order to evaluate tubular damage in diabetic patients, the activity of renal proximal tubule derived enzymes excreted in 24-hour urine were recorded in 5 groups as follows: (i) 48 noninsulin-independent diabetic patients with normal renal function and a urinary albumin excretion rate within the normal range; (ii) 45 noninsulin-dependent diabetic patients with normal renal function and a high urinary albumin level; (iii) 26 noninsulin-dependent diabetic patients with renal failure; (iv) 40 patients with essential hypertension and normal renal function, and (v) 48 normal control subjects. Regardless of whether cases were noninsulin-dependent diabetics with normal or high urinary albumin excretion rate or cases with renal dysfunction, urinary dipeptidyl aminopeptidase IV and N-acetyl-beta-D-glucosaminidase excretions were significantly higher than in healthy subjects, and urinary gamma-glutamyl transpeptidase excretion was significantly lower than in healthy subjects. No significant changes in urinary enzyme excretions showed specific variations in the essential hypertensive patients. These results suggest that there is tubular damage in the early stages of noninsulin-dependent diabetic patients with normal renal function and normal urinary albumin excretion rate. Detection of urinary excretion of dipeptidyl aminopeptidase IV, N-acetyl-beta-D-glucosaminidase and gamma-glutamyl transpeptidase may be especially useful for the early diagnosis of diabetic nephropathy.


Assuntos
Acetilglucosaminidase/urina , Diabetes Mellitus Tipo 2/enzimologia , Nefropatias Diabéticas/diagnóstico , Dipeptidil Peptidase 4/urina , Hipertensão/enzimologia , gama-Glutamiltransferase/urina , Albuminúria , Fosfatase Alcalina/urina , Antígenos CD13/urina , Ensaios Enzimáticos Clínicos , Creatinina/urina , Diabetes Mellitus Tipo 2/complicações , Nefropatias Diabéticas/enzimologia , Feminino , Glucose/metabolismo , Humanos , Túbulos Renais Proximais/enzimologia , Leucil Aminopeptidase/urina , Masculino , Pessoa de Meia-Idade , Microglobulina beta-2/urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...